Document Detail


Portable enhanced external counterpulsation for acute coronary syndrome and cardiogenic shock: a pilot study.
MedLine Citation:
PMID:  17492675     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Enhanced external counterpulsation (EECP) currently is used as an outpatient therapy for patients with refractory chronic angina. HYPOTHESIS: We sought to determine the safety and feasibility of a portable EECP unit to treat patients with acute coronary syndrome and/or cardiogenic shock in the coronary care unit (CCU). METHODS: Ten patients with acute coronary syndrome and/or cardiogenic shock who were not considered candidates for invasive intra-aortic balloon counterpulsation (IABP) by the treating cardiologist were prospectively enrolled in this single-center study. Each patient received 2-4 one-hour EECP treatments performed at the bedside in the CCU. Anticoagulation or recent femoral access was not an exclusion criterion. RESULTS: The mean age was 58 +/- 19 years (range 28-81), and half were women. Patients had either acute coronary syndrome alone (n = 4), cardiogenic shock alone (n = 3), or both (n = 3). The cardiac indications for study enrollment included: acute inferior wall ST-segment elevation myocardial infarction with cardiogenic shock (n = 2), non-ST-segment elevation myocardial infarction with postinfarction angina (n = 2) or heart failure (n = 1), unstable angina with refractory rest angina (n = 2), cardiogenic shock from ischemic cardiomyopathy with severe mitral regurgitation (n = 1), and cardiogenic shock from nonischemic cardiomyopathy (n = 2). No adverse events were recorded during or as a consequence of EECP therapy, including no bleeding complications, no heart failure exacerbations, and no skin breakdown. The portable EECP unit did not interfere with ongoing critical care nursing. CONCLUSIONS: EECP is safe and feasible for acute bedside therapy of critically ill patients with acute coronary syndrome and/or cardiogenic shock who are not candidates for IABP.
Authors:
Joshua Cohen; William Grossman; Andrew D Michaels
Related Documents :
7611485 - Predicting the potential gradient field in ventricular fibrillation from shocks deliver...
21081555 - Can intracoronary stem cell injection permanently improve cardiac function after myocar...
1225345 - Titrated energy cardioversion of patients on digitalis.
19940765 - Comparison of early and long-term results of percutaneous coronary interventions in pat...
22234385 - Contemporary use of glycoprotein iib/iiia inhibitors.
8945035 - Single lead ddd system: a comparative evaluation of unipolar, bipolar, and overlapping ...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Clinical cardiology     Volume:  30     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  2007 May 
Date Detail:
Created Date:  2007-05-16     Completed Date:  2007-06-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  223-8     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Department of Medicine, University of California at San Francisco Medical Center, San Francisco, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Angina, Unstable / physiopathology,  therapy*
Counterpulsation*
Electrocardiography
Female
Humans
Male
Middle Aged
Myocardial Infarction / physiopathology,  therapy*
Pilot Projects
Shock, Cardiogenic / physiopathology,  therapy*
Stroke Volume

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Angiogenesis in the caprine caruncles in non-pregnant and pregnant normal and swainsonine-treated do...
Next Document:  QT dispersion and prognosis after coronary stent placement in acute myocardial infarction.